This inventor holds 1 USPTO granted patent. Top assignee: Uniquest Pty Limited. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Riccardo Turrini: Innovator in Monoclonal Antibody Development
Introduction
Riccardo Turrini is a notable inventor based in Albignasego, Italy. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work is characterized by a commitment to advancing medical science and improving therapeutic options.
Latest Patents
Riccardo holds a patent for an anti-BARF1 monoclonal antibody. This invention relates to a new anti-BARF1 monoclonal antibody, which has potential applications in treating various diseases. His innovative approach in this area showcases his dedication to addressing critical health challenges.
Career Highlights
Riccardo is associated with Uniquest Pty Limited, where he continues to push the boundaries of research and development. His career is marked by a focus on creating impactful solutions in the medical field. With a patent portfolio that includes 1 patent, he exemplifies the role of inventors in driving scientific progress.
Collaborations
Throughout his career, Riccardo has collaborated with esteemed colleagues such as Antonio Rosato and Riccardo Dolcetti. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Riccardo Turrini stands out as an influential inventor in the realm of monoclonal antibodies. His contributions are paving the way for advancements in medical treatments, and his work continues to inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile